Vistagen Therapeutics, Inc.

US$0.16As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:VTGNHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (48.16%)
Div yield —
ROE (166.46%)
Biotechnology
Beta (5Y) 0.47
PE TTM —
TSR TTM (95.84%)
Mkt cap US$7.269M
ROIC (103.20%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.169
3.10%
(76.41%)
Hold 4|4|10|2|3
3Q26
4Q26
1Q27
2Q27
Earnings per share$
—
—
—
—
(3.27%)
(1.90%)
13.05%
1.70%
Revenue$M
0.405
0.426
0.414
0.428
8.46%
8.06%
0.40%
3.28%
Peers (US$7.269M)
Cap (US$)
PE
7.291M
—
Capital
TTM
5Y
10Y
Leveragex
3.717
0.090
0.084
EBIT/Intx
0.159
1.372
0.939
Own earn%
(26.23)
12.65
12.59
Sh yield%
25.81
36.19
30.08
Owners
Insiders/Inst%
0.73
42.72
Short interest%
5.92
SBC / revenue%
1.62
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
6
Op margin range%
5–12
$1 testx
—
Incr. ROIC%
25